Aesculap’s A-FIX Spinal System Receives FDA Clearance

Aesculap Implant Systems of Center Valley, Penn., received FDA 510k clearance for the A-FIX Spinal System, a stand-alone interbody spinal fusion device, according to a company news release.

Advertisement

The system was designed for the anterior surgical approach to spinal fusion procedures at one or two continuous levels in the lumbar spine from L2 to S1. The system should be used with patients suffering from degenerative disc disease with up to Grade 1 spondylolisthesis.

Read the release on Aesculap A-FIX Spinal System.

Read more coverage on Aesculap:

– Aesculap Launches New Pedicle Screw System

– Aesculap Implant System Launches Spyder MIS Retractor System

– 26 Orthopedic and Spine Devices Receive FDA Clearance in July

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.